This deletion partially disrupts SLC2A14 and entirely deletes SLC2A3 and NANOGP1. Since NANOGP1 is expressed but untranslated and SLC2A14 is only expressed in the testes, they are not obvious candidates for a direct role in RA. The gene discussed is SLC2A3; the disease is rheumatoid arthritis.